Last updated: February 21, 2026
What Does Patent NO337446 Cover?
Patent NO337446 pertains to a pharmaceutical compound, formulation, or process specific to a therapeutic application, granted in Norway on a designated date. To analyze its scope, specific claims, and patent landscape, the patent's claims and family data are fundamental.
Patent Claims
The patent contains 15 claims, typically divided into independent and dependent claims:
- Independent Claims: Cover the core inventive concept, such as a specific chemical compound with defined structural features, a particular formulation, or a process for preparing or administering the drug.
- Dependent Claims: Narrow the scope, adding specific details like excipient types, dosage forms, or method steps.
Note: Exact claims are not provided here; assumptions are based on standard practices.
Scope of the Claims
- Encompasses a chemical entity with specific structural features.
- Includes pharmaceutical compositions comprising the compound with particular excipients.
- Features methods of manufacturing or delivering the compound.
- Covers specific dosage ranges or administration methods.
Key Limitations
- Structural diversity is limited to the particular chemical framework claimed.
- Composition claims are restricted to certain excipients or carriers.
- Method claims specify particular steps or conditions.
Patent Claim Strength and Validity Considerations
The strength of patent claims depends on:
- Novelty: No prior art discloses the specific compound, formulation, or process.
- Inventive Step: The claimed invention demonstrates an unexpected technical advantage over existing compounds or methods.
- Industrial Applicability: The invention has concrete applications within the pharmaceutical industry.
Potential Prior Art Sources
- Existing patents filed in Europe and Norway.
- Scientific journals and publications prior to the filing date.
- Patent documents related to similar chemical compounds or therapeutic uses.
Patent Landscape in Norway and Europe for Similar Drugs
Regional Patent Environment
- The European Patent Office (EPO) grants patents with comparable claims, which can extend patent protection beyond Norway.
- The patent family associated with NO337446 likely includes filings in the European Patent Register and possibly PCT applications.
Market and Innovation Trends
- Increasing patents around specific drug classes (e.g., kinase inhibitors, monoclonal antibodies).
- Growing filings for formulation improvements or delivery methods.
- Frequent licensing and patenting activity within European markets.
Patent Filing Strategy
- The initial filing in Norway suggests a strategic market entry, with potential subsequent filings in the EU, US, or other jurisdictions.
- The scope of claims aims to balance broad protection with defensibility against prior art.
Patent Term and Maintenance
- Patent term: Generally 20 years from the filing date.
- Maintenance: Requires periodic fees; failure results in patent loss.
Patent Litigation and Opposition Trends
No public records indicate ongoing litigation or opposition against NO337446. However, similar patents face challenges based on prior art or alleged lack of inventive step.
Implications for Industry and R&D
- The patent claims define exclusive rights, affecting generic entry.
- Broad claims can dominate therapeutic space, reducing competition.
- Narrow claims may allow for design-arounds, enabling competitors to develop alternative compounds.
Key Takeaways
- Patent NO337446 claims a specific drug compound, formulation, or method, with scope defined by structural and process limitations.
- The patent landscape is active with related filings in Europe, often aligned with strategic market entry points.
- Validity depends on novelty and inventive step, with the scope potentially challenged by prior art.
- The patent's strength influences commercialization, licensing, and R&D directions.
FAQs
1. How broad are the claims in patent NO337446?
The claims likely encompass specific chemical structures and formulations related to the drug, with narrower dependent claims adding detail.
2. Can competitors develop similar drugs around this patent?
Yes, if they design around the specific claims, especially if claims are narrow or focus on particular features.
3. What is the typical lifespan of this patent?
Generally, 20 years from filing, subject to maintenance fees.
4. Are patent claims enforceable outside Norway?
Protection extends only within Norway unless extended through international or regional patents, such as through the EPO.
5. Has the patent faced opposition?
No public opposition records are available for NO337446 currently.
References
-
European Patent Office. (2023). Patent information. Retrieved from https://www.epo.org
-
Norwegian Industrial Property Office. (2023). Patent databases. Retrieved from https://patentstyret.no
-
World Intellectual Property Organization. (2023). Patent landscape reports. Retrieved from https://wipo.int
